Pet Healthcare in Singapore

  • ID: 4515382
  • Report
  • Region: Singapore
  • 39 pages
  • MarketLine
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Eli Lilly and Company
  • Pfizer Inc.
  • MORE
Pet Healthcare in Singapore

Summary

Pet Healthcare in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Singapore pet healthcare market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights
  • The pet healthcare market comprises the retail sale of pet supplements, worming treatments, external parasite treatments, grooming products and other pet healthcare. The market is valued according to the retail selling price (RSP) and includes any applicable taxes. All currency conversions have been made using constant annual average 2016 exchange rates.
  • The Singaporean pet healthcare market had total revenues of $9.1m in 2016, representing a compound annual growth rate (CAGR) of 5.0% between 2012 and 2016.
  • Market consumption volume increased with a CAGR of 4.0% between 2012 and 2016, to reach a total of 1.1 million units in 2016.
  • Pet humanization, and an increasing trend towards owners spending more on health and wellness products for their pets, are the primary factors driving the Singaporean pet healthcare market.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in Singapore
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in Singapore
  • Leading company profiles reveal details of key pet healthcare market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pet healthcare market with five year forecasts by both value and volume
Reasons to buy
  • What was the size of the Singapore pet healthcare market by value in 2016?
  • What will be the size of the Singapore pet healthcare market in 2021?
  • What factors are affecting the strength of competition in the Singapore pet healthcare market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Singapore's pet healthcare market?
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Eli Lilly and Company
  • Pfizer Inc.
  • MORE
Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Eli Lilly and Company
Mct Aromatics-Botls Agencies
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related Research
Appendix
About the Author

List of Tables
Table 1: Singapore pet healthcare market value: $ million, 2012-16
Table 2: Singapore pet healthcare market volume: million units, 2012-16
Table 3: Singapore pet healthcare market category segmentation: $ million, 2016
Table 4: Singapore pet healthcare market geography segmentation: $ million, 2016
Table 5: Singapore pet healthcare market share: % share, by value, 2016
Table 6: Singapore pet healthcare market distribution: % share, by value, 2016
Table 7: Singapore pet healthcare market value forecast: $ million, 2016-21
Table 8: Singapore pet healthcare market volume forecast: million units, 2016-21
Table 9: Bayer AG: key facts
Table 10: Bayer AG: key financials ($)
Table 11: Bayer AG: key financials (€)
Table 12: Bayer AG: key financial ratios
Table 13: Eli Lilly and Company: key facts
Table 14: Eli Lilly and Company: key financials ($)
Table 15: Eli Lilly and Company: key financial ratios
Table 16: Mct Aromatics-Botls Agencies: key facts
Table 17: Pfizer Inc.: key facts
Table 18: Pfizer Inc.: key financials ($)
Table 19: Pfizer Inc.: key financial ratios
Table 20: Singapore size of population (million), 2012-16
Table 21: Singapore gdp (constant 2005 prices, $ billion), 2012-16
Table 22: Singapore gdp (current prices, $ billion), 2012-16
Table 23: Singapore inflation, 2012-16
Table 24: Singapore consumer price index (absolute), 2012-16
Table 25: Singapore exchange rate, 2012-16

List of Figures
Figure 1: Singapore pet healthcare market value: $ million, 2012-16
Figure 2: Singapore pet healthcare market volume: million units, 2012-16
Figure 3: Singapore pet healthcare market category segmentation: % share, by value, 2016
Figure 4: Singapore pet healthcare market geography segmentation: % share, by value, 2016
Figure 5: Singapore pet healthcare market share: % share, by value, 2016
Figure 6: Singapore pet healthcare market distribution: % share, by value, 2016
Figure 7: Singapore pet healthcare market value forecast: $ million, 2016-21
Figure 8: Singapore pet healthcare market volume forecast: million units, 2016-21
Figure 9: Forces driving competition in the pet healthcare market in Singapore, 2016
Figure 10: Drivers of buyer power in the pet healthcare market in Singapore, 2016
Figure 11: Drivers of supplier power in the pet healthcare market in Singapore, 2016
Figure 12: Factors influencing the likelihood of new entrants in the pet healthcare market in Singapore, 2016
Figure 13: Factors influencing the threat of substitutes in the pet healthcare market in Singapore, 2016
Figure 14: Drivers of degree of rivalry in the pet healthcare market in Singapore, 2016
Figure 15: Bayer AG: revenues & profitability
Figure 16: Bayer AG: assets & liabilities
Figure 17: Eli Lilly and Company: revenues & profitability
Figure 18: Eli Lilly and Company: assets & liabilities
Figure 19: Pfizer Inc.: revenues & profitability
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • Eli Lilly and Company
  • Mct Aromatics-Botls Agencies
  • Pfizer Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll